B. Haugen

发表

Towards improving the utility of fine‐needle aspiration biopsy for the diagnosis of thyroid tumours

B. Haugen, W. Woodmansee, M. Mcdermott, 2002, Clinical endocrinology.

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

S. Mandel, Y. Nikiforov, D. Steward, 2009, Thyroid : official journal of the American Thyroid Association.

Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma

P. Ladenson, V. Hertzberg, B. Haugen, 1998, Annals of Internal Medicine.

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Stephanie L. Lee, R. Kloos, S. Mandel, 2009, Thyroid : official journal of the American Thyroid Association.

Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer

A. Tan, B. Haugen, S. Sams, 2014, Molecular Cancer.

Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients.

D. Lezotte, B. Haugen, M. Mcdermott, 2001, Thyroid : official journal of the American Thyroid Association.

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

R. Wahl, R. Kloos, P. Ladenson, 2006, The Journal of clinical endocrinology and metabolism.

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.

Markus Luster, Michael Lassmann, Marcel Ricard, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Papillary Thyroid Cancer

B. Haugen, J. Sipos, 2021, Surgery of the Thyroid and Parathyroid Glands.

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?

B. Haugen, Bryan R Haugen, 2017, Cancer.

Thyroid – Differentiated and Anaplastic Carcinoma

J. Shah, E. Rohren, J. Hunt, 2017 .

American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with

S. Mandel, A. Nassar, D. Steward, 2017, Thyroid : official journal of the American Thyroid Association.

American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence‐based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules

S. Wiseman, M. Urken, L. Morris, 2019, Head & neck.

Molecular Diagnostic Evaluation of Thyroid Nodules.

B. Haugen, Sarah E. Mayson, 2019, Endocrinology and metabolism clinics of North America.

Multicenter clinical experience with the Afirma gene expression classifier.

S. Mandel, D. Steward, B. Haugen, 2014, The Journal of clinical endocrinology and metabolism.

Thyroid Cancer 2 Progress in molecular-based management of diff erentiated thyroid cancer

M. Schlumberger, B. Haugen, M. Xing, 2013 .

A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation

G. Kennedy, R. Kloos, S. Mandel, 2013, Annals of Internal Medicine.

The impact of age and gender on papillary thyroid cancer survival.

J. Jonklaas, J. Robbins, P. Ladenson, 2012, The Journal of clinical endocrinology and metabolism.

Chapter 25 – Solitary Thyroid Nodule

B. Haugen, S. Said, 2009 .

Laryngeal examination in thyroid and parathyroid surgery: An American Head and Neck Society consensus statement

B. Haugen, G. Randolph, Jennifer J Shin, 2016, Head & neck.

Comprehensive Immune Profiling of Medullary Thyroid Cancer.

F. Hirsch, B. Haugen, C. Rivard, 2020, Thyroid : official journal of the American Thyroid Association.

Effect of dietary macronutrient composition on tissue-specific lipoprotein lipase activity and insulin action in normal-weight subjects.

R. Eckel, B. Haugen, D. Jensen, 1998, The American journal of clinical nutrition.

A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

B. Weintraub, P. Ladenson, M. Luster, 1999, The Journal of clinical endocrinology and metabolism.

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

Stephanie L. Lee, P. Ladenson, G. Braunstein, 2003, The Journal of clinical endocrinology and metabolism.

Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer

B. Haugen, E. Stamm, K. Garg, 2018, American Journal of Neuroradiology.

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

C. Korch, J. Fagin, B. Haugen, 2019, Molecular Cancer Research.

American Thyroid Association Guidelines and Statements: Past, Present, and Future.

J. Jonklaas, P. Kopp, B. Haugen, 2018, Thyroid : official journal of the American Thyroid Association.

A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines.

J. Jonklaas, S. Mandel, P. Kopp, 2019, Thyroid : official journal of the American Thyroid Association.

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

C. Korch, R. Smallridge, A. Tan, 2019, Clinical Cancer Research.

The 2015 American Thyroid Association Evidence-Based Guidelines for Management of Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Key Recommendations

B. Haugen, 2018 .

Radioiodine remnant ablation: current indications and dosing regimens.

B. Haugen, 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.

R. Wahl, R. Kloos, P. Ladenson, 2009, The Journal of clinical endocrinology and metabolism.

Recurrence after treatment of micropapillary thyroid cancer.

J. Jonklaas, P. Ladenson, D. Steward, 2009, Thyroid : official journal of the American Thyroid Association.

Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.

P. Ladenson, J. Brierley, B. Haugen, 1998, Cancer.

Management of the patient with progressive radioiodine non-responsive disease.

B. Haugen, 1999, Seminars in surgical oncology.

Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin.

B. Haugen, M. Mcdermott, E. Ridgway, 2002, Thyroid : official journal of the American Thyroid Association.

Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.

P. Ladenson, J. Brierley, B. Haugen, 1998, Thyroid : official journal of the American Thyroid Association.

Authors’ Response: A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma

P. Ladenson, G. Braunstein, A. Pinchera, 2003 .

Thyroid targeted Kras(G12D)/Pten(-/-) mice and their cell lines: new tools to study thyroid cancer biology.

B. Haugen, R. Schweppe, 2011, Thyroid : official journal of the American Thyroid Association.

Outcomes of Bethesda categories III and IV thyroid nodules over 5 years and performance of the Afirma gene expression classifier: A single‐institution study

B. Haugen, Carrie B. Marshall, N. Pozdeyev, 2018, Clinical endocrinology.

Radioiodine therapy in patients with stage I differentiated thyroid cancer.

J. Jonklaas, P. Ladenson, D. Steward, 2010, Thyroid : official journal of the American Thyroid Association.

Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.

B. Haugen, S. Said, J. Klopper, 2010, The Journal of clinical endocrinology and metabolism.

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Gerard M Doherty, Stephanie L. Lee, R. Kloos, 2006, Thyroid : official journal of the American Thyroid Association.

Expanding indications for recombinant human TSH in thyroid cancer.

M. Luster, M. Schlumberger, B. Haugen, 2008, Thyroid : official journal of the American Thyroid Association.

Excessive survivin expression in thyroid lymphomas.

F. Moatamed, B. Haugen, F. Matsuzuka, 2002, Human pathology.

Isotope imaging for metastatic thyroid cancer.

E. Lin, B. Haugen, Bryan R. Haugen, 2001, Endocrinology and metabolism clinics of North America.

The management of subclinical hyperthyroidism by thyroid specialists.

B. Haugen, W. Woodmansee, M. Mcdermott, 2003, Thyroid : official journal of the American Thyroid Association.

Does the metabolic activity of metastatic thyroid carcinoma correlate with prognosis?

B. Haugen, 2006, Nature Clinical Practice Endocrinology &Metabolism.

PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells

B. Haugen, Laura A. Pike, Vibha Sharma, 2011, PPAR research.

mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines.

L. Joosten, M. Netea, W. Oyen, 2014, The Journal of clinical endocrinology and metabolism.

Editorial: SESTAMIBI: OPENING A NEW ERA OF PARATHYROID SURGICAL PROCEDURES

R. McIntyre, B. Haugen, E. Ridgway, 1998 .

A review of the potential uses for recombinant human TSH in patients with thyroid cancer and nodular goiter

B. Haugen, W. Woodmansee, 2004, Clinical endocrinology.

Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.

B. Haugen, J. Klopper, Vibha Sharma, 2004, The Journal of clinical endocrinology and metabolism.

Initial Treatment of Differentiated Thyroid Carcinoma

B. Haugen, 2000, Reviews in Endocrine and Metabolic Disorders.

Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment.

B. Haugen, J. Hershman, J. Klopper, 2004, Molecular cancer therapeutics.

Retinoid X receptor-γ and peroxisome proliferator-activated receptor-γ expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment

B. Haugen, J. Hershman, J. Klopper, 2004, Molecular Cancer Therapeutics.

Chapter 34 – Hypothyroidism

B. Haugen, K. Weber, 2009 .

Development and characterization of six new human papillary thyroid carcinoma cell lines.

Michelle D. Williams, B. Haugen, G. Clayman, 2015, The Journal of clinical endocrinology and metabolism.

Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma

K. Shroyer, T. Enomoto, B. Haugen, 2002, Acta obstetricia et gynecologica Scandinavica.

Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium.

K. Shroyer, T. Enomoto, B. Haugen, 2002, Gynecologic oncology.

Drugs that suppress TSH or cause central hypothyroidism.

B. Haugen, 2009, Best practice & research. Clinical endocrinology & metabolism.

Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer

H. Shibata, B. Haugen, A. Berlinberg, 2015, PloS one.

Structural and functional characterization of the genomic locus encoding the murine beta 2 thyroid hormone receptor.

B. Haugen, W. Wood, E. Ridgway, 1994, Molecular endocrinology.

Central hypothyroidism associated with retinoid X receptor-selective ligands.

B. Haugen, S. Sherman, M. Duvic, 1999, The New England journal of medicine.

A "safe and effective" protocol for management of post-thyroidectomy hypocalcemia.

R. McIntyre, B. Haugen, J. Klopper, 2015, American journal of surgery.

Pit-1 Expression, Regulation, and Modulation of Multiple Pituitary Genes

B. Haugen, W. Wood, D. Gordon, 2000 .

Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablation.

B. Haugen, 2004, The Journal of clinical endocrinology and metabolism.

The combination of Pit-1 and Pit-1T have a synergistic stimulatory effect on the thyrotropin beta-subunit promoter but not the growth hormone or prolactin promoters.

B. Haugen, W. Wood, E. Ridgway, 1994, Molecular endocrinology.

Comprehensive Immune Proﬁling of Medullary Thyroid Cancer

F. Hirsch, B. Haugen, C. Rivard, 2020 .

Reverse Transcription Polymerase Chain Reaction Analysis of Pituitary Hormone, Pit-1 and Steroidogenic Factor-1 Messenger RNA Expression in Pituitary Tumors

B. Haugen, M. Mcdermott, K. Lillehei, 2004, Pituitary.

The Effect of Vitamin A, Retinoids and Retinoid Receptors on the Hypothalamic-Pituitary-Thyroid Axis

B. Haugen, 2004 .

Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.

B. Haugen, S. Said, J. Klopper, 2010, The Journal of clinical endocrinology and metabolism.

Tailoring the approach to radioactive iodine treatment in thyroid cancer.

B. Haugen, Sarah E. Mayson, Christine M Chan, 2021, Endocrine-related cancer.

A thyrotrope-specific variant of Pit-1 transactivates the thyrotropin beta promoter.

B. Haugen, W. Wood, E. Ridgway, 1993, The Journal of biological chemistry.

Analysis of Pit-1 in regulating mouse TSH β promoter activity in thyrotropes

B. Haugen, V. Sarapura, W. Wood, 1993, Molecular and Cellular Endocrinology.

Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.

F. Khuri, A. Gramza, B. Haugen, 2014, Thyroid : official journal of the American Thyroid Association.

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

M. Nikiforova, Y. Nikiforov, D. Steward, 2009, The Journal of clinical endocrinology and metabolism.

Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression

B. Haugen, S. Said, J. Klopper, 2009, Molecular Cancer.

A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.

B. Weintraub, P. Ladenson, M. Luster, 2006, The Journal of clinical endocrinology and metabolism.

Secondary malignancy of the thyroid gland: a case report and review of the literature.

P. Bunn, K. Shroyer, B. Haugen, 1994, Thyroid : official journal of the American Thyroid Association.

Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?

Nancy D Perrier, B. Haugen, R. Tuttle, 2017, Thyroid : official journal of the American Thyroid Association.

Progress in molecular-based management of differentiated thyroid cancer

M. Schlumberger, B. Haugen, M. Xing, 2013, The Lancet.

Retinoid X Receptor γ-Deficient Mice Have Increased Skeletal Muscle Lipoprotein Lipase Activity and Less Weight Gain when Fed a High-Fat Diet

R. Eckel, P. Chambon, B. Haugen, 2004 .

Characterization of Thyroid Cancer Cell Lines in Murine Orthotopic and Intracardiac Metastasis Models

B. Haugen, S. Sams, Jennifer A Morrison, 2015, Hormones and Cancer.

Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology

Simion I. Chiosea, K. Ngiam, S. Mandel, 2018, JAMA oncology.

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

E. Sokol, A. Tan, B. Haugen, 2018, Clinical Cancer Research.

Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis

Xia Jing, Qiong Zhou, B. Haugen, 2012, Clinical Cancer Research.

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Christopher Korch, Rebecca E Schweppe, C. Korch, 2008, The Journal of clinical endocrinology and metabolism.

Evolving approaches to patients with advanced differentiated thyroid cancer.

B. Haugen, S. Sherman, 2013, Endocrine reviews.

Approach to the thyroid cancer patient with extracervical metastases.

B. Haugen, M. Kane, 2010, The Journal of clinical endocrinology and metabolism.

Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer

A. Tan, B. Haugen, S. Sams, 2014, Molecular Cancer.

A rexinoid antagonist increases the hypothalamic–pituitary–thyroid set point in mice and thyrotrope cells

C. Sladek, B. Haugen, Vibha Sharma, 2011, Molecular and Cellular Endocrinology.

Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects.

B. Haugen, W. Woodmansee, S. Sherman, 2007, The Journal of clinical endocrinology and metabolism.

Thyroid hormone resistance and increased metabolic rate in the RXR-γ–deficient mouse

R. Eckel, P. Chambon, B. Haugen, 2000 .

A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial.

F. Khuri, A. Gramza, B. Haugen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Telomerase activity in benign and malignant thyroid tumors.

K. Shroyer, B. Haugen, B. Werness, 1997, Thyroid : official journal of the American Thyroid Association.

Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.

R. Agarwal, B. Haugen, G. Deep, 2014, The Journal of clinical endocrinology and metabolism.

Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis.

P. Chambon, B. Haugen, A. Bianco, 2006, Endocrinology.

The Thyrotrope-Restricted Isoform of the Retinoid-X Receptor-γ1 Mediates 9-cis-Retinoic Acid Suppression of Thyrotropin-β Promoter Activity

B. Haugen, W. Wood, E. Ridgway, 1997 .

Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse.

R. Eckel, P. Chambon, B. Haugen, 2000, The Journal of clinical investigation.

Influence of human immune cells on cancer: studies at the University of Colorado

Kimberly R. Jordan, M. McCarter, B. Haugen, 2012, Immunologic Research.

Influence of human immune cells on cancer: studies at the University of Colorado

Kimberly R. Jordan, M. McCarter, B. Haugen, 2012, Immunologic Research.

Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer.

B. Haugen, Vibha Sharma, A. Kerege, 2009, The Journal of clinical endocrinology and metabolism.

Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models

B. Haugen, M. Jeon, 2022, Endocrinology and metabolism.

Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion

B. Haugen, K. Bauerle, R. Schweppe, 2010, Molecular Cancer.

Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

B. Haugen, J. Klopper, Vibha Sharma, 2009, PPAR research.

Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition.

B. Haugen, A. Gutierrez-Hartmann, Vibha Sharma, 2009, Thyroid : official journal of the American Thyroid Association.

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.

Darya Chudova, James Diggans, Juan Rosai, 2012, The New England journal of medicine.

The risks and benefits of radioiodine therapy for thyroid carcinoma remain somewhat undifferentiated.

B. Haugen, 2000, Thyroid : official journal of the American Thyroid Association.

The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.

K. Shroyer, B. Haugen, S. Nawaz, 2004, American journal of clinical pathology.

Pit-1 and GATA-2 Interact and Functionally Cooperate to Activate the Thyrotropin β-Subunit Promoter*

B. Haugen, M. Mcdermott, W. Wood, 1997, The Journal of Biological Chemistry.

Prospective multicenter study of thyroid carcinoma treatment

P. Ladenson, J. Brierley, B. Haugen, 1998 .

Leveraging the immune system to treat advanced thyroid cancers.

B. Haugen, K. Bible, C. Spitzweg, 2017, The lancet. Diabetes & endocrinology.

Applications of proteomics to thyroid neoplasms: are we there yet?

B. Haugen, M. Duncan, 2010, Thyroid : official journal of the American Thyroid Association.

Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue

K. Shroyer, B. Haugen, S. Helmke, 2006, Molecular carcinogenesis.

Tumor‐specific changes in mtDNA content in human cancer

S. Sukumar, A. Chatterjee, D. Sidransky, 2005, International journal of cancer.

Outcomes of patients with differentiated thyroid carcinoma following initial therapy.

J. Jonklaas, P. Ladenson, J. Brierley, 2006, Thyroid : official journal of the American Thyroid Association.

Discovery and validation of protein abundance differences between follicular thyroid neoplasms.

B. Haugen, P. Slootweg, S. Helmke, 2008, Cancer research.

Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.

J. Jonklaas, P. Ladenson, D. Steward, 2015, The Journal of clinical endocrinology and metabolism.

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies

A. Tan, B. Haugen, Minjae Yoo, 2016, Oncotarget.

Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.

R. McIntyre, K. Davies, B. Haugen, 2016, The Journal of clinical endocrinology and metabolism.

The thyrotrope-restricted isoform of the retinoid-X receptor-gamma1 mediates 9-cis-retinoic acid suppression of thyrotropin-beta promoter activity.

B. Haugen, W. Wood, E. Ridgway, 1997, Molecular endocrinology.

N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.

D. Forrest, T. Curran, B. Haugen, 1995, Molecular endocrinology.

Lenvatinib plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer.

Alan K. Mayberry, B. Haugen, E. Donadi, 2021, Thyroid : official journal of the American Thyroid Association.

PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer

R. McIntyre, B. Haugen, S. Sams, 2015, Cancer Immunology Research.

Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer.

R. McIntyre, B. Haugen, S. Said, 2012, The Journal of clinical endocrinology and metabolism.

Cytopathologic Diagnosis of Thyroid Nodules Varies Considerably

G. Kennedy, R. Kloos, S. Mandel, 2013 .

ADVERSE EVENT REPORTING IN PATIENTS TREATED WITH THYROID HORMONE EXTRACT.

B. Haugen, J. Hennessey, Rupendra T. Shrestha, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the american thyroid association, american association of clinical endocrinologists, and the endocrine society.

B. Haugen, J. Hennessey, A. Malabanan, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Radioiodine Effects on the Nasolacrimal System.

B. Haugen, K. Burman, Susan Mandel, 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Tofacitinib in Active Ulcerative Colitis

G. Kennedy, B. Haugen, E. Alexander, 2012 .

Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.

S. Karam, D. Raben, B. Haugen, 2018, Thyroid : official journal of the American Thyroid Association.

Determinants of thyrotrope-specific thyrotropin beta promoter activation. Cooperation of Pit-1 with another factor.

B. Haugen, M. Mcdermott, W. Wood, 1996, Journal of Biological Chemistry.

In vivo and Microarray Analysis of Rexinoid-Responsive Anaplastic Thyroid Carcinoma

Meenakshi Singh, B. Haugen, J. Klopper, 2008, Clinical Cancer Research.

SPECT/CT of metastatic struma ovarii.

B. Haugen, P. Koo, Brian M. Bagrosky, 2013, Clinical nuclear medicine.

Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.

J. Jonklaas, P. Ladenson, D. Steward, 2014, Thyroid : official journal of the American Thyroid Association.

Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers

A. Tan, A. Thor, B. Jacobsen, 2020, Clinical Cancer Research.

Lenvatinib plus pembrolizumab combination therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC): Results of a multicenter phase II international thyroid oncology group trial.

N. Foster, B. Haugen, F. Worden, 2020 .

Ultrasound‐based clinical prediction rule model for detecting papillary thyroid cancer in cervical lymph nodes: A pilot study

B. Haugen, D. Glueck, J. Klopper, 2016, Journal of clinical ultrasound : JCU.

Summary of the Third World Congress on Thyroid Cancer.

J. Shah, B. Haugen, E. Cohen, 2018, Thyroid : official journal of the American Thyroid Association.

Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?

S. Mandel, Y. Nikiforov, D. Steward, 2021, Thyroid : official journal of the American Thyroid Association.

Thyroid cancer: CAR T cell therapy — potential in advanced thyroid cancer?

B. Haugen, J. French, 2018, Nature Reviews Endocrinology.

Redifferentiation therapy in advanced thyroid cancer.

B. Haugen, 2004, Current Drug Targets - Immune, Endocrine & Metabolic Disorders.

Thyroid-Specific T Cells in Patients With Differentiated Thyroid Cancer: Implications for Immune-Based Therapies?

B. Haugen, J. French, 2017, The Journal of clinical endocrinology and metabolism.

Computer-Assisted Levothyroxine Dose Selection for the Treatment of Postoperative Hypothyroidism.

B. Haugen, Robert McIntyre, N. Pozdeyev, 2023, Thyroid : official journal of the American Thyroid Association.

Congenital isolated central hypothyroidism caused by a "hot spot" mutation in the thyrotropin-beta gene.

B. Haugen, M. Mcdermott, W. Wood, 2002, Thyroid : official journal of the American Thyroid Association.

Pioglitazone Therapy of PAX8-PPARγ Fusion Protein Thyroid Carcinoma.

T. Giordano, E. Caoili, B. Haugen, 2018, The Journal of clinical endocrinology and metabolism.

Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet.

R. Eckel, P. Chambon, B. Haugen, 2004, Endocrinology.

Thyroid Cancer Guidelines Task Force Disclosure Information

Stephanie L. Lee, R. Kloos, S. Mandel, 2009 .

Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.

J. Jonklaas, P. Ladenson, D. Steward, 2015, Thyroid.

Isolation and Functional Analysis of the Mouse RXRγ1 Gene Promoter in Anterior Pituitary Cells*

E. Linney, B. Haugen, Qiang Liu, 2002, The Journal of Biological Chemistry.

Thyroid Hormone Receptor β2 Promoter Activity in Pituitary Cells Is Regulated by Pit-1*

B. Haugen, M. Mcdermott, W. Wood, 1996, The Journal of Biological Chemistry.

Can calcitonin and carcinoembryonic antigen doubling times predict progression of thyroid carcinoma?

B. Haugen, J. Klopper, 2008, Nature Clinical Practice Endocrinology &Metabolism.

What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision.

S. Mandel, Y. Nikiforov, B. Haugen, 2021, Thyroid.

S. Mandel, A. Nassar, D. Steward, 2017, Thyroid : official journal of the American Thyroid Association.

Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1

J. Copland, R. Smallridge, B. Haugen, 2006, Oncogene.

Evolving approaches to patients with advanced differentiated thyroid cancer.

B. Haugen, S. Sherman, 2013, Endocrine reviews.

Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.

F. Khuri, A. Gramza, B. Haugen, 2014, Thyroid : official journal of the American Thyroid Association.

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

M. Nikiforova, Y. Nikiforov, D. Steward, 2009, The Journal of clinical endocrinology and metabolism.

Thyroid cancer polygenic risk score combined with deep learning analysis of ultrasound images improves the classification of thyroid nodules as benign or malignant

B. Haugen, N. Rafaels, M. Dighe, 2023, medRxiv.

Drugs that suppress TSH or cause central hypothyroidism.

B. Haugen, 2009, Best practice & research. Clinical endocrinology & metabolism.

Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer.

B. Haugen, Vibha Sharma, J. French, 2009, The Journal of clinical endocrinology and metabolism.

Susceptibility of Snails to Infection with Schistosomes is influenced by Temperature and Expression of Heat Shock Proteins

N. Raghavan, B. Haugen, M. Smith, 2015, Epidemiology.